Deutsche Interdisziplinäre Vereinigung für Intensiv- und Notfallmedizin e.V.
Mitte, 10117, Germany
NCT Number: NCT04674371
It has now been 90 years since Werner Forssmann developed the CVC. Nowadays CVCs play an integral role for critically ill patients.
Despite the high number of central venous access devices inserted annually, there are limited data on the incidence of the associated procedural complications, many of which carry substantial clinical risk. This point was highlighted in recently published Association of Anaesthetists of Great Britain and Ireland "Safe vascular access 2016" guidelines and "Clinical guidelines on central venous catheterisation" in 2014 of the Swedish Society of Anaesthesiology and Intensive Care Medicine.
This German point prevalence study should identify the number of central venous catheter insertions and the incidence of various and especially serious mechanical complications across multiple hospital sites within one day.
Secondary aims are to identify the availability of resources and infrastructure to facilitate safe central venous catheter insertion and management of potential complications.
As much hospital sites as possible should participate and identify all adult central venous catheter insertions, with subsequent review of any complications detected.
Additionally, resources while inserting the CVC should be specified such as ultrasound for assessment of ultrasound anatomy and/or ultrasound-guidance. Furthermore, assessment of the CVC tip should be studied whether done during CVC placement with
* ECG-guidance or by * transthoracic/transesophageal ultrasound with the Microbubble test or more conventional post hoc with * bedside chest X-ray Any mechanical complication should be documented untill day three post insertion. The background is to identify possible perforations due to initially unfavorable CVC tip positions (angle > 40 ° to wall of the superior vena cava).
Participation in the study is open to all disciplines (anesthesia, intensive care, internal medicine, surgery, etc.) that regularly perform CVCs.
Looking for future studies?
Notify MeAll sexes
Observational
Mitte, 10117, Germany
Questions
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Age
Procedures
Providers
Selection of catheter insertion site
Complications
Every operator should perform the CVC Insertion Procedure according to his common clinical practice.
Time frame: 17.05.2022
All patients with a CVC Insertion on May 17th. 2022 in participating Hospitals independent of sex, age or BMI in kg/m^2 are eligible
Time frame: 17.05.2022-20.05.2022
Which complications and malpositions occur within 72 h
Time frame: 17.05.2022
How many emergency patients will be included in the study
Time frame: 17.05.2022
distribution of the punctured vessels (external jugular, internal jugular, subclavian, femoral
) and that of the respective sides
Time frame: 17.05.2022
Resident physician/ Specialist doctor
Time frame: 17.05.2022
How many puncture attempts are necessary to achieve a successful CVC
Time frame: 17.05.2022
What catheter types and which caliber in French are being inserted
Time frame: 17.05.2022
witch and how often do problems with the Seldinger-wire occur
Time frame: 17.05.2022
Screening / Online guidance / Short or long axis view
Time frame: 17.05.2022
measures to ensure central venous catheter tip position (i.e. CXR, ECG method and ultrasound)
Wolfram Schummer, MD, PhD
Other
German Point Prevalence Study on Central Venous Catheter
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07499830
Arterial Occlusive Diseases, Arteriosclerosis
Beijing, China
View Trial DetailsNCT06550349
Data Collection
Cardiff, United Kingdom
View Trial DetailsNCT05992805
Data Collection
Cardiff, United Kingdom
View Trial DetailsNCT07371559
Behavior, Data Collection
Shenzhen, Guangdong, China
View Trial Details